News Center
In March 2022, congratulations to Lairuisen Pharmaceuticals on successfully passing the evaluation and activating the registration status "A" for the import declaration of raw materials oseltamivir and efaviren. Welcome to cooperate.
Copyright(C)2024,Beijing Lunarsun Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle 31fabu Copyright Notice